EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Functional Recovery by Transplantation of Human iPSC-Derived A2B5 Positive Neural Progenitor Cell After Spinal Cord Injury in Mice

Yiyan Zheng iD, Xiaohui Chen iD, Ping Bu iD, Haipeng Xue, Dong H Kim, Hongxia Zhou, Xugang Xia, Ying Liu iD, Qilin Cao iD

International Journal of Molecular Sciences · 2025

DOI: 10.3390/ijms26188940 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Yiyan Zheng und 8 weiteren Autor:innen. Beteiligte Einrichtung: Center for Translational Science, Florida International University, 11350 SW Village Pkwy, Port St. Lucie, FL 34987, USA. Hauptthemen laut MEDLINE: Spinal Cord Injuries, Induced Pluripotent Stem Cells, Neural Stem Cells, Recovery of Function. Die Arbeit nennt 72 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NINDS NIH HHS, NIH HHS, Craig H Neilsen Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Human induced pluripotent stem cells (hiPSCs) hold great potential for patient-specific therapies. Transplantation of hiPSC-derived neural progenitor cells (NPCs) is a promising reparative strategy for spinal cord injury (SCI), but clinical translation requires efficient differentiation into desired neural lineages and purification before transplantation. Here, differentiated hiPSCs—reprogrammed from human skin fibroblasts using Sendai virus-mediated expression of OCT4, SOX2, KLF4, and C-MYC—into neural rosettes expressing SOX1 and PAX6, followed by neuronal precursors (β-tubulin III+/NESTIN+) and glial precursors (GFAP+/NESTIN+). Both neuronal and glial precursors expressed the A2B5 surface antigen. A2B5+ NPCs, purified by fluorescence-activated cell sorting (FACS), proliferated in vitro with mitogens, and differentiated into mature neurons and astrocytes under lineage-specific conditions. Then, NOD-SCID mice received a T9 contusion injury followed by transplantation of A2B5+ NPCs, human fibroblasts, or control medium at 8 days post-injury. At two months, grafted NPCs showed robust survival, progressive neuronal maturation (β-tubulin III+→doublecortin+→NeuN+), and astrocytic differentiation (GFAP+), particularly in spared white matter. Transplantation significantly increased spared white matter volume and improved hindlimb locomotor recovery, with no teratoma formation observed. These results demonstrate that hiPSC-derived, FACS-purified A2B5+ NPCs can survive, differentiate into neurons and astrocytes, and enhance functional recovery after SCI. This approach offers a safe and effective candidate cell source for treating SCI and potentially other neurological disorders.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Spinal Cord InjuriesInduced Pluripotent Stem CellsNeural Stem CellsRecovery of FunctionStem Cell TransplantationAnimalsHumansKruppel-Like Factor 4MiceCell DifferentiationMice, SCIDMice, Inbred NODNeuronsDisease Models, Animal

Stichwörter der Autor:innen

hiPSCneural repairneural stem cellsspinal cord injurytransplantation

Substanzen

Kruppel-Like Factor 4Klf4 protein, mouseKLF4 protein, human

Autor:innen und Institutionen

  • Center for Translational Science, Florida International University, 11350 SW Village Pkwy, Port St. Lucie, FL 34987, USA.
  • Department of Environmental Health Sciences, Robert Stempel College of Public Health and Social Work, Florida International University, 11200 SW 8th Street, Miami, FL 33199, USA.
  • Vivian L Smith Department of Neurosurgery, University of Texas Health Science Center at Houston, Houston, TX 77030, USA.
  • Center for Stem Cell and Regenerative Medicine, The Brown Foundation Institute of Molecular Medicine for the Prevention of Human Diseases, University of Texas Health Science Center at Houston, 6431 Fannin Street, Housto…

ORCID-Profile: Yiyan Zheng, Xiaohui Chen, Ping Bu, Ying Liu, Qilin Cao

Förderung

  • NINDS NIH HHS
  • NIH HHS
  • Craig H Neilsen Foundation
  • United States Department of Defense
  • Wellcome Trust
  • FIU start-up funds, Craig H. Neilsen Foundation awards

Zitieren

APA

Zheng, Y., Chen, X., Bu, P., Xue, H., Kim, D. H., Zhou, H., Xia, X., Liu, Y., & Cao, Q. (2025). Functional Recovery by Transplantation of Human iPSC-Derived A2B5 Positive Neural Progenitor Cell After Spinal Cord Injury in Mice. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms26188940

Vancouver

Zheng Y, Chen X, Bu P, Xue H, Kim DH, Zhou H, et al. Functional Recovery by Transplantation of Human iPSC-Derived A2B5 Positive Neural Progenitor Cell After Spinal Cord Injury in Mice. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms26188940

BibTeX
@article{Zheng2025,
  author = {Zheng, Yiyan and Chen, Xiaohui and Bu, Ping and Xue, Haipeng and Kim, Dong H and Zhou, Hongxia and Xia, Xugang and Liu, Ying and Cao, Qilin},
  title = {Functional Recovery by Transplantation of Human iPSC-Derived A2B5 Positive Neural Progenitor Cell After Spinal Cord Injury in Mice},
  journal = {International Journal of Molecular Sciences},
  year = {2025},
  doi = {10.3390/ijms26188940}
}
Kostenlos starten →